Jeffrey L. Johnson v. HHS - Pneumococcal, Guillain-Barré syndrome (2019)

Filed 2017-11-17Decided 2019-11-21Vaccine Pneumococcal
compensated$185,000

Case summary [AI summaries can sometimes make mistakes]

Jeffrey L. Johnson filed a petition on November 17, 2017, alleging that he developed Guillain-Barré syndrome (GBS) as a result of receiving a pneumococcal (Prevnar) vaccine on or about April 28, 2016.

The respondent, the Secretary of Health and Human Services, denied that the vaccine caused Mr. Johnson's GBS.

Despite maintaining their respective positions, both parties agreed to settle the case. A stipulation was filed on September 24, 2019, outlining the terms of the settlement.

The court reviewed the stipulation and found it to be reasonable, adopting it as its decision. The settlement awarded Mr.

Johnson a lump sum payment of $185,000.00, intended to compensate for all elements of damages available under the National Vaccine Injury Compensation Program. This decision was issued by Special Master Brian H.

Corcoran on November 21, 2019. The case proceeded as a Table claim, as GBS is listed on the Vaccine Injury Table for the pneumococcal vaccine.

Source PDFs 3 total · 2 downloaded